2′-deoxyuridine | CAS:951-78-0

We serve 2′-deoxyuridine CAS:951-78-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2'-deoxyuridine

Chemical Name:2'-deoxyuridine
CAS.NO:951-78-0
Synonyms:Deoxy-uridin
Uracildeoxyr
[3H]-Deoxyuridine
Deoxyuridine
1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Molecular Formula:C9H12N2O5
Molecular Weight:228.20200
 
Physical and Chemical Properties:
Density:1.533
Melting point:167-169ºC
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥99.0%
Loss on drying:≤1.0%
Heavy metal:≤10ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As therapeutic agent for treating allergy, cancer, infection and autoimmune disease.



Contact us for information like Deoxy-uridin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[3H]-Deoxyuridine Use and application,[3H]-Deoxyuridine technical grade,usp/ep/jp grade.


Related News: The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.1,2,3-Triacetyl-5-deoxy-D-ribose manufacturer British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.5-Methyl-3-nitropicolinonitrile supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.2-Fluoro-3-Chloro-5-Bromopyridine vendor Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.